1Brange J, Owens DR, Kang S, Volund A. Monomeric insulins and their experimental and clinical implications. Diabetes Care,1990,13:923-954.
2Tamas G, Matte M, Astorga R, et al. Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study. Diabetes Res Clin Pract, 2001,54: 105-114.
3Raskin P, Guthrie RA, Leiter L, et al. Use of insulin a spart, afast acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care,2000,23 : 583-588.
4Home PD, Lindholm A, Riis A, et al. Insulin aspart vs. human insulin in the management of long term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.Diabet Med, 2000,17 : 762- 770.
5Pramming S, Thorsteinsson B, Bendtson I, et al. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med,1991,8:217-222.
6Melki V, Renard E, Lassmann-Vague V, et al. Improvement of HbAlc and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care,1998,21,977-982.
